sglt2inhib
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| sglt2inhib [2026/04/09 05:32] – [Adverse effects and contra-indications] gary1 | sglt2inhib [2026/04/09 05:32] (current) – [Adverse effects and contra-indications] gary1 | ||
|---|---|---|---|
| Line 28: | Line 28: | ||
| *causes glycosuria and osmotic diuresis with ~5x increased risk of UTIs, balanitis, vulvovaginitis and dehydration | *causes glycosuria and osmotic diuresis with ~5x increased risk of UTIs, balanitis, vulvovaginitis and dehydration | ||
| * this increases the risk of **[[fourniers]]** | * this increases the risk of **[[fourniers]]** | ||
| - | *may contribute to risk of [[ARF|acute kidney injury]] especially if on [[ACEIs]], [[ARBs]] and [[NSAIDs]] | + | *may contribute to risk of **[[ARF|acute kidney injury]]** especially if on [[ACEIs]], [[ARBs]] and [[NSAIDs]] |
| ***may cause euglycaemic [[dm_dka_SGLT2]]!** | ***may cause euglycaemic [[dm_dka_SGLT2]]!** | ||
sglt2inhib.txt · Last modified: 2026/04/09 05:32 by gary1